The LD-VenEx Phase II Clinical Trial: An ex Vivo Flow Cytometry Based-Drug Screening of AML Patient Samples
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
AML, venetoclax, VEN, flow cytometry, Phase II, azacitidine, AZA
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要